Provided by Tiger Trade Technology Pte. Ltd.

ClearPoint Neuro, Inc.

13.46
+0.89007.08%
Post-market: 13.40-0.0600-0.45%19:57 EST
Volume:422.75K
Turnover:5.62M
Market Cap:400.41M
PE:-16.29
High:13.60
Open:12.70
Low:12.70
Close:12.57
52wk High:30.10
52wk Low:9.76
Shares:29.75M
Float Shares:25.97M
Volume Ratio:0.60
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8264
EPS(LYR):-0.6998
ROE:-103.13%
ROA:-28.30%
PB:25.22
PE(LYR):-19.23

Loading ...

ClearPoint Neuro CEO Joseph Burnett Reports Sale of Common Shares

Reuters
·
Jan 28

ClearPoint Neuro Receives EU MDR Certification for Navigation Software 3.0.2

Reuters
·
Jan 23

Community Financial System to Acquire ClearPoint Federal Bank & Trust for $40 Million

Reuters
·
Jan 15

ClearPoint Neuro CEO Joseph Burnett Reports Disposal of Common Shares

Reuters
·
Jan 14

Lake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT)

TIPRANKS
·
Jan 13

ClearPoint Neuro Projects 2026 Revenue of $54 to $60 Million

Reuters
·
Jan 12

ClearPoint Neuro Amends Note Purchase Agreement With $20 Million Financing Linked to IRRAS Acquisition

Reuters
·
Jan 05

Adagio Medical Holdings Appoints Sean Salmon to Board of Directors

Reuters
·
Dec 11, 2025

ClearPoint Neuro Completes Acquisition of IRRAS

Reuters
·
Nov 21, 2025

CLS Wins FDA Clearance for Expanded MRI Use of Neuro Laser Therapy System

Reuters
·
Nov 14, 2025

ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 39% Cheaper Price Remains In Tune With Revenues

Simply Wall St.
·
Nov 10, 2025

ClearPoint Neuro Q3 EPS $(0.21) Misses $(0.20) Estimate, Sales $8.861M Miss $9.600M Estimate

Benzinga
·
Nov 07, 2025

BRIEF-ClearPoint Neuro Q3 Revenue USD 8.9 Million

Reuters
·
Nov 07, 2025

ClearPoint Neuro Narrows 2025 Revenue Guidance to $36–38 Million

Reuters
·
Nov 07, 2025

Clearpoint Neuro Q3 Gross Margin 63%

THOMSON REUTERS
·
Nov 07, 2025

Clearpoint Neuro Q3 Operating Expenses USD 10.9 Million

THOMSON REUTERS
·
Nov 07, 2025

Clearpoint Neuro Outlook FY Revenue USD 36-38 Million

THOMSON REUTERS
·
Nov 07, 2025

ClearPoint Neuro Acquires IRRAS to Expand Brain Treatment Portfolio

Reuters
·
Nov 07, 2025

ClearPoint Neuro Down Over 24%, on Pace for Largest Percent Decrease Since July 2017 -- Data Talk

Dow Jones
·
Nov 04, 2025

Top Premarket Decliners

MT Newswires Live
·
Nov 03, 2025